PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
KMED vs. KARS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between KMED and KARS is 0.51, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.5

Performance

KMED vs. KARS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in KraneShares Emerging Markets Healthcare Index ETF (KMED) and KraneShares Electric Vehicles & Future Mobility Index ETF (KARS). The values are adjusted to include any dividend payments, if applicable.

-10.00%0.00%10.00%20.00%30.00%JulyAugustSeptemberOctoberNovemberDecember0
10.12%
KMED
KARS

Key characteristics

Returns By Period


KMED

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

KARS

YTD

-15.45%

1M

-1.50%

6M

10.12%

1Y

-13.64%

5Y*

0.26%

10Y*

N/A

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


KMED vs. KARS - Expense Ratio Comparison

KMED has a 0.79% expense ratio, which is higher than KARS's 0.70% expense ratio.


KMED
KraneShares Emerging Markets Healthcare Index ETF
Expense ratio chart for KMED: current value at 0.79% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.79%
Expense ratio chart for KARS: current value at 0.70% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.70%

Risk-Adjusted Performance

KMED vs. KARS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for KraneShares Emerging Markets Healthcare Index ETF (KMED) and KraneShares Electric Vehicles & Future Mobility Index ETF (KARS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
No data
The chart of Calmar ratio for KMED, currently valued at 0.00, compared to the broader market0.005.0010.0015.000.00-0.22
KMED
KARS


Rolling 12-month Sharpe Ratio-1.50-1.00-0.500.00JulyAugustSeptemberOctoberNovemberDecember
-1.00
-0.45
KMED
KARS

Dividends

KMED vs. KARS - Dividend Comparison

KMED has not paid dividends to shareholders, while KARS's dividend yield for the trailing twelve months is around 0.76%.


TTM202320222021202020192018
KMED
KraneShares Emerging Markets Healthcare Index ETF
0.00%100.66%0.21%0.39%0.02%1.70%0.00%
KARS
KraneShares Electric Vehicles & Future Mobility Index ETF
0.76%0.88%1.13%6.73%0.14%1.85%1.39%

Drawdowns

KMED vs. KARS - Drawdown Comparison


-65.00%-60.00%-55.00%-50.00%JulyAugustSeptemberOctoberNovemberDecember
-52.13%
-57.03%
KMED
KARS

Volatility

KMED vs. KARS - Volatility Comparison

The current volatility for KraneShares Emerging Markets Healthcare Index ETF (KMED) is 0.00%, while KraneShares Electric Vehicles & Future Mobility Index ETF (KARS) has a volatility of 10.06%. This indicates that KMED experiences smaller price fluctuations and is considered to be less risky than KARS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%JulyAugustSeptemberOctoberNovemberDecember0
10.06%
KMED
KARS
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab